US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

165.73

+2.351.44%

Pre-market: 165.770.0400+0.02%08:56 EDT

Volume:10.02M

Turnover:1.66B

Market Cap:11.52B

PE:9.09

High:167.91

Open:164.60

Low:163.74

Close:163.38

52wk High:169.68

52wk Low:88.60

Shares:69.53M

Float Shares:69.53M

Volume Ratio:1.04

T/O Rate:14.41%

Dividend:0.56

Dividend Rate:0.34%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says

MT Newswires Live

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live

Legend Biotech Price Target Cut to $58.00/Share from $59.00 by RBC Capital

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)

Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)

Goldman Sachs Reaffirms Their Buy Rating on Legend Biotech (LEGN)

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

Kaisa Health Calls Special Meeting to Approve Biotech-Focused Name Change

TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

MT Newswires Live

Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pliant Therapeutics (PLRX)

Table: Panion & BF Biotech 2Q Net Profit Nt$39.1m vs Nt$38.0m

Ship Healthcare Holdings Sees 1H Net Y5.50b

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)

OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/XBI/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":165.73,"timestamp":1787342400000,"preClose":163.38,"halted":0,"volume":10016422,"hourTrading":{"tag":"盘前","latestPrice":165.77,"preClose":165.73,"latestTime":"08:56 EDT","volume":7182,"amount":1190567.322,"timestamp":1787576204630,"change":0.04,"changeRate":0.000241,"amplitude":0.006147},"delay":0,"changeRate":0.014383645489043912,"floatShares":69525000,"shares":69525000,"eps":18.23,"marketStatus":"Pre-Mkt","change":2.35,"latestTime":"08-24 08:58:44 EDT","open":164.6,"high":167.9112,"low":163.74,"amount":1663136725.302,"amplitude":0.025531,"askPrice":165.85,"askSize":100,"bidPrice":165.28,"bidSize":1,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":165.73,"sharesOutstanding":63325000,"nav":165.682052,"aum":11336794406.12,"dividendRate":0.0034,"bidAskSpread":0.000298,"preHourTrading":{"tag":"盘前","latestPrice":165.77,"preClose":165.73,"latestTime":"08:56 EDT","volume":7182,"amount":1190567.322,"timestamp":1787576204630,"change":0.04,"changeRate":0.000241,"amplitude":0.006147},"postHourTrading":{"tag":"盘后","latestPrice":166.35,"preClose":165.73,"latestTime":"19:59 EDT","volume":85473,"amount":14172263.124,"timestamp":1787356794970,"change":0.62,"changeRate":0.003741,"amplitude":0.005008},"volumeRatio":1.0362914545448074,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"157.0","timestamp":1787329639281,"price":2.21,"volume":1350,"amount":298350,"type":"-"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"150.0","timestamp":1787329639281,"price":0.99,"volume":1350,"amount":133650,"type":"+"}]},"impliedVol":0.3255,"impliedVolPercentile":0.732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":69525000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0362914545448074,"shares":69525000,"dividePrice":0.5635,"high":167.9112,"amplitude":0.025531,"preClose":163.38,"low":163.74,"week52Low":88.6,"pbRate":"--","week52High":169.68,"institutionHeld":0.8511,"latestPrice":165.73,"committee":-0.980198,"eps":18.23,"divideRate":0.0034,"volume":10016422,"delay":0,"ttmEps":18.23,"open":164.6,"prevYearClose":121.93,"prevWeekClose":165.73,"prevMonthClose":147.01,"prevQuarterClose":158.25,"fiveDayClose":157.41,"twentyDayClose":150.48,"sixtyDayClose":134.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659901648","title":"Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901648?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:00","pubTimestamp":1786554032,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NextCure (NXTC) and CalciMedica (CALC). NextCure (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nextcure-nxtc-and-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","CALC","BK4581","XLV","BK4137","BK4585","LU0029874061.USD","BK4139","HCSG","BK4007","XBI","NXTC","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901615","title":"Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901615?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:50","pubTimestamp":1786553410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4575","XBI","BK4121","BK4588","LABU","LU0029874061.USD","LU0128526141.USD","BK4007","XLV","BK4137","BK4581","BNGO","BK4585","PYPD","LQDA","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658909519","title":"Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658909519","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658909519?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:58","pubTimestamp":1786550316,"startTime":"0","endTime":"0","summary":"Legend Biotech  could see pressures from competition and its recent leadership change, potentially weighing on its Carvykti myeloma therapy strategy, Oppenheimer said in a Wednesday note.Chief Executive Ying Huang resigned from the company in July and his departure raised concerns over strategies as Anito-cel nears potential approval and commercialization as a competing myeloma treatment, the investment firm said.Anito-cel's approval could pressure Legend Biotech's stock and Carvykti's near-term growth, but Oppenheimer noted that it continues to expect Carvykti to corner a majority of the market share in multiple myeloma.Carvykti sales could still peak at about $5 billion, but its near-term position could depend on the new CEO's strategic vision, the brokerage said.Oppenheimer downgraded Legend Biotech to perform from outperform and adjusted the price target to $40 from $75.Price: 20.66, Change: -1.17, Percent Change: -5.36","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEMS","BK4588","BK4505","BK4127","LEGN","CANC","OPY","MEDI","BK4581","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658690574","title":"Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658690574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658690574?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:01","pubTimestamp":1786546891,"startTime":"0","endTime":"0","summary":"Legend Biotech  is positioned to sustain profitability after achieving adjusted net income profitability in Q2 and given its existing cash runway, RBC Capital Markets said.Revenue increased to $387.5 million from $255.1 million. Revenue growth was mainly driven by myeloma therapy Carvykti, according to the note Tuesday.Carvykti's market share as an earlier-line treatment for myeloma continues to grow. RBC said the 2nd-to-4th-line market remains underpenetrated by BCMA-targeting therapies.The investment firm believes near-term risk to Carvykti, developed in collaboration with Johnson & Johnson , from bispecifics and future CAR-T entrants is being overstated. The continued investment by Legend and J&J supports the drug's growth outlook, according to the note.Johnson & Johnson has reiterated Carvykti's potential to generate more than $5 billion in annual sales.RBC has an outperform rating on the stock and lowered its price target to $58 from $59.Shares of Legend Biotech were down 3.4% in ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","CANC","IXJ","LU0943347566.SGD","LU1145028129.USD","LU2133065610.SGD","IHE","TRUH","LU2487616109.SGD","JDOC","FHLC","BK4533","XBI","SGXZ57979304.SGD","LU0787776722.HKD","LU1074936037.SGD","IE00BKVL7J92.USD","LU0098860793.USD","LU0124676726.USD","XLV","LEGN","LU0072461881.USD","LU0683600562.USD","LU1066053197.SGD","IE00BFTCPJ56.SGD","MEDX","LU1066051811.HKD","LU2505996681.GBP","RXL","IE000WAW04H5.SGD","LU1244550577.SGD","MEDI","LU1196500208.SGD","BK4532","LU2602419157.SGD","VHT","LU1989771016.USD","PJP","BK4585","BK4588","LU0689472784.USD","IE00BSNM7G36.USD","BMED","GDOC","JNJ","MEMS","IYH","LU0795875169.SGD","LU0640476718.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903284","title":"Legend Biotech Price Target Cut to $58.00/Share from $59.00 by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903284","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903284?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:16","pubTimestamp":1786544160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658709499","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658709499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658709499?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:50","pubTimestamp":1786539013,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","GMAB","BK4139","XBI","BK4581","ATAI","BK4007","BK4588","LABU","XLV","BK4167","DH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970958","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: AIM ImmunoTech (AIM) and Schrodinger (SDGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970958?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:40","pubTimestamp":1786538419,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AIM ImmunoTech (AIM) and Schrodinger (SDGR). AIM ImmunoTech (AIM)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aim-immunotech-aim-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-aim-immunotech-aim-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","XBI","LABU","BK4137","AIM","BK4167","BK4581","HCSG","LU0128526141.USD","SDGR","XLV","LU0029874061.USD","BK4557","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997785","title":"Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997785?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537240,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 908 Devices (MASS), Pediatrix Medical Group (MD) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","MASS","XLV","BK4588","BK4585","BK4581","MD","BK4139","LABU","XBI","LU0128526141.USD","BBOT","LU0029874061.USD","BK4157","BK4196","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658720519","title":"Goldman Sachs Reaffirms Their Buy Rating on Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658720519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658720519?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:19","pubTimestamp":1786537191,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Ziyi Chen maintained a Buy rating on Legend Biotech today and set a price target of $40.70. According to TipRanks, Chen is a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974286","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974286?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:40","pubTimestamp":1786534824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Maze Therapeutics, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","LFSC","XLV","MAZE","TVTX","BK4563","XBI","FFTY","BK4581","LU0029874061.USD","IMNM","LU0128526141.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974444","title":"Kaisa Health Calls Special Meeting to Approve Biotech-Focused Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974444?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:38","pubTimestamp":1786534705,"startTime":"0","endTime":"0","summary":"Kaisa Health Group Holdings Limited ( ($HK:0876) ) has issued an update. Kaisa Health Group Holdings Limited has convened a special general meeting...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kaisa-health-calls-special-meeting-to-approve-biotech-focused-name-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kaisa-health-calls-special-meeting-to-approve-biotech-focused-name-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974237","title":"TransMedics Buy Rating Reaffirmed as Analyst Maintains $95 Price Target on Robust Multi-Year Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974237?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:35","pubTimestamp":1786534533,"startTime":"0","endTime":"0","summary":"TransMedics Group, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William Plovanic from Canaccord Genuity...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/transmedics-buy-rating-reaffirmed-as-analyst-maintains-95-price-target-on-robust-multi-year-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/transmedics-buy-rating-reaffirmed-as-analyst-maintains-95-price-target-on-robust-multi-year-growth-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974863","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974863?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Brookdale Senior Livi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","BKD","LEGN","BK4532","BK4185","LU1674673691.USD","SG9999001176.USD","TBXU","HCSG","IE00B19Z3581.USD","LABU","LU0061475181.USD","MEDI","GNMX","VERX","LU0432979614.USD","IDNA","LU1778281490.HKD","XLV","BK4588","LU0029874061.USD","SG9999001176.SGD","LU1430594728.SGD","LU1499592464.USD","IBB","MEMS","LU0234570918.USD","LU2089984988.USD","IE0002270589.USD","LU2417539215.USD","IE00B19Z3B42.SGD","BIB","PBE","IE00B894F039.SGD","LU0417517546.SGD","LU0058720904.USD","VRTX","LU2237438978.USD","LU0757428866.USD","XBI","CANC","IE00BZ9MQY76.HKD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU1585245621.USD","IBBQ","LU1815336091.USD","BK4505","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658762249","title":"RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658762249","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658762249?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:28","pubTimestamp":1786530498,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) has an average rating of overweight and mean price target of $49.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658764239","title":"Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658764239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658764239?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:15","pubTimestamp":1786529746,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Trucchio from H.C. Wainw...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harmony-biosciences-strengthening-core-business-and-pipeline-support-unchanged-55-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harmony-biosciences-strengthening-core-business-and-pipeline-support-unchanged-55-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","LABU","XLV","HRMY","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978453","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pliant Therapeutics (PLRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978453?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:50","pubTimestamp":1786524608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tecan Group AG (TCHBF), Kyverna Therapeutics, Inc. (KYTX) and Pli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-tecan-group-ag-othertchbf-kyverna-therapeutics-inc-kytx-and-pliant-therapeutics-plrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-tecan-group-ag-othertchbf-kyverna-therapeutics-inc-kytx-and-pliant-therapeutics-plrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LABU","SLJY","SLVR","XBI","BK4007","XLV","PLRX","BK4585","HCSG","BK4139","KYTX","AG","SLVX","LU0029874061.USD","BK4588","TCHBF","SILJ","TCGGY","LU0128526141.USD","BK4121","BK4210","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658783269","title":"Table: Panion & BF Biotech 2Q Net Profit Nt$39.1m vs Nt$38.0m","url":"https://stock-news.laohu8.com/highlight/detail?id=2658783269","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658783269?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:48","pubTimestamp":1786524480,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969920","title":"Ship Healthcare Holdings Sees 1H Net Y5.50b","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:39","pubTimestamp":1786523940,"startTime":"0","endTime":"0","summary":"Ship Healthcare Holdings Inc. also released the following forecasts:. Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4137","HCSG","XBI","XLV","BK4588","LU0128526141.USD","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927217","title":"Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927217?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:10","pubTimestamp":1786522207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elanco Animal Health (ELAN) and ACADIA Pharmaceutica...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elanco-animal-health-elan-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elanco-animal-health-elan-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BK4139","LU2065171402.SGD","BK4581","LU2065170008.USD","LU2065169927.USD","LABU","XLV","BK4561","LU1941712264.USD","ELAN","LU0128526141.USD","HCSG","LU2065171311.SGD","BK4585","ACAD","XBI","BK4137","BK4007","LU1941712348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658245269","title":"OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2658245269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658245269?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:59","pubTimestamp":1786517941,"startTime":"0","endTime":"0","summary":"OLBA HEALTHCARE HOLDINGS, Inc. ( ($JP:2689) ) has issued an update. OLBA Healthcare Holdings reported consolidated net sales of ¥126,595 million fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/olba-healthcare-profit-slips-as-balance-sheet-strengthens-ahead-of-dvx-integration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/olba-healthcare-profit-slips-as-balance-sheet-strengthens-ahead-of-dvx-integration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","BK4585","BK4137","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":16,"totalSize":383,"code":"91000000","status":"200"}]}}